Abstract
Psychiatric conditions are common and can affect gynecologic conditions and their treatment outcomes. Gynecologists encounter psychiatric conditions in the outpatient settings and during perioperative periods. Common gynecologic surgeries such as hysterectomy, sterilization, and dilatation and curettage have significant impact on psychological well-being of women. Delirium is common after surgeries for gynecologic conditions. Colposcopy, an outpatient procedure used for the diagnosis and treatment of cervical dysplasia, is associated with anxiety before, during, and after the procedure. Depression and anxiety are common psychiatric disorders in women; these and other psychiatric conditions will be examined in the context of uterine leiomyoma, endometriosis, polycystic ovarian disease, urinary incontinence, pelvic prolapse, and gynecologic cancers. Finally, in the last section, therapeutic approaches for psychiatric comorbidities in the gynecologic patient and psychotropics for nonpsychiatric conditions are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Oliphant SS, Jones KA, Wang L, Bunker CH, Lowder JL. Trends over time with commonly performed obstetric and gynecologic inpatient procedures. Obstet Gynecol. 2010;116(4):926–31.
Fingar KR, Stocks C, Weiss AJ, Steiner CA. Most frequent operating room procedures performed in U.S. hospitals, 2003–2012: statistical brief #186. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality (US); 2006.
Moore BJ, Steiner CA, Davis PH, Stocks C, Barrett ML. Trends in hysterectomies and oophorectomies in hospital inpatient and ambulatory settings, 2005–2013: statistical brief #214. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality (US); 2006.
Barrett ML, Weiss AJ, Stocks C, Steiner CA, Myers ER. Procedures to treat benign uterine fibroids in hospital inpatient and hospital-based ambulatory surgery settings, 2013: statistical brief #200. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality (US); 2006.
Steiner CA, Karaca Z, Moore BJ, Imshaug MC, Pickens G. Surgeries in hospital-based ambulatory surgery and hospital inpatient settings, 2014: statistical brief #223. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality (US); 2006.
Doll KM, Dusetzina SB, Robinson W. Trends in inpatient and outpatient hysterectomy and oophorectomy rates among commercially insured women in the United States, 2000-2014. JAMA Surg. 2016;151(9):876–7.
Andryjowicz E, Wray T. Regional expansion of minimally invasive surgery for hysterectomy: implementation and methodology in a large multispecialty group. Perm J. 2011;15(4):42–6.
Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med. 1993;328(12):856–60.
Darwish M, Atlantis E, Mohamed-Taysir T. Psychological outcomes after hysterectomy for benign conditions: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;174:5–19.
Gibson CJ, Bromberger JT, Weiss GE, Thurston RC, Sowers M, Matthews KA. Negative attitudes and affect do not predict elective hysterectomy: a prospective analysis from the Study of Women’s Health Across the Nation. Menopause. 2011;18(5):499–507.
Ryan MM, Dennerstein L, Pepperell R. Psychological aspects of hysterectomy. A prospective study. Br J Psychiatry. 1989;154:516–22.
Thakar R, Ayers S, Georgakapolou A, Clarkson P, Stanton S, Manyonda I. Hysterectomy improves quality of life and decreases psychiatric symptoms: a prospective and randomised comparison of total versus subtotal hysterectomy. BJOG. 2004;111(10):1115–20.
Flory N, Bissonnette F, Binik YM. Psychosocial effects of hysterectomy: literature review. J Psychosom Res. 2005;59(3):117–29.
Thakar R. Dispelling the myth--does hysterectomy cause pelvic organ dysfunction? BJOG. 2004;111(Suppl 1):20–3.
Vandyk AD, Brenner I, Tranmer J, Van Den Kerkhof E. Depressive symptoms before and after elective hysterectomy. J Obstet Gynecol Neonatal Nurs. 2011;40(5):566–76.
Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer. 1948;1(2):177–83.
Morley GW, Hopkins MP, Lindenauer SM, Roberts JA. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol. 1989;74(6):934–43.
Arnaboldi P, Santoro L, Mazzocco K, Oliveri S, Maggioni A, Pravettoni G. The paradox of pelvic exenteration: the interaction of clinical and psychological variables. Int J Gynecol Cancer. 2015;25(8):1534–40.
Committee on Ethics. Committee opinion no. 695: sterilization of women: ethical issues and considerations. Obstet Gynecol. 2017;129(4):e109–e16.
Hillis SD, Marchbanks PA, Tylor LR, Peterson HB. Poststerilization regret: findings from the United States collaborative review of sterilization. Obstet Gynecol. 1999;93(6):889–95.
Schmidt JE, Hillis SD, Marchbanks PA, Jeng G, Peterson HB. Requesting information about and obtaining reversal after tubal sterilization: findings from the U.S. collaborative review of sterilization. Fertil Steril. 2000;74(5):892–8.
Curtis KM, Mohllajee AP, Peterson HB. Regret following female sterilization at a young age: a systematic review. Contraception. 2006;73(2):205–10.
Shreffler KM, Greil AL, McQuillan J, Gallus KL. Reasons for tubal sterilisation, regret and depressive symptoms. J Reprod Infant Psychol. 2016;34(3):304–13.
Brier N. Grief following miscarriage: a comprehensive review of the literature. J Womens Health (Larchmt). 2008;17(3):451–64.
Brier N. Anxiety after miscarriage: a review of the empirical literature and implications for clinical practice. Birth. 2004;31(2):138–42.
Robinson GE. In: Fogel BS, Greenberg DB, editors. Psychiatric care of the medical patient. 3rd ed. Oxford/New York: Oxford University Press; 2015.
DTS L, Cheung LP, Haines CJ, KPM C, TKH C. A comparison of the psychologic impact and client satisfaction of surgical treatment with medical treatment of spontaneous abortion: a randomized controlled trial. Am J Obstet Gynecol. 2001;185(4):953–8.
Marteau TM, Walker P, Giles J, Smail M. Anxieties in women undergoing colposcopy. Br J Obstet Gynaecol. 1990;97(9):859–61.
Kola-Palmer S, Walsh JC. Correlates of psychological distress immediately following colposcopy. Psychooncology. 2015;24(7):819–24.
Galaal K, Bryant A, Deane KH, Al-Khaduri M, Lopes AD. Interventions for reducing anxiety in women undergoing colposcopy. Cochrane Database Syst Rev. 2011;12:Cd006013.
O’Connor M, O’Leary E, Waller J, Gallagher P, D’Arcy T, Flannelly G, et al. Trends in, and predictors of, anxiety and specific worries following colposcopy: a 12-month longitudinal study. Psychooncology. 2016;25(5):597–604.
Parikh SS, Chung F. Postoperative delirium in the elderly. Anesth Analg. 1995;80(6):1223–32.
McAlpine JN, Hodgson EJ, Abramowitz S, Richman SM, Su Y, Kelly MG, et al. The incidence and risk factors associated with postoperative delirium in geriatric patients undergoing surgery for suspected gynecologic malignancies. Gynecol Oncol. 2008;109(2):296–302.
Wang S, Allen D, Kheir YN, Campbell N, Khan B. Aging and post-intensive care syndrome: a critical need for geriatric psychiatry. Am J Geriatr Psychiatry. 2017;26(2):212–21.
Gunderson CC, Walter AC, Ruskin R, Ding K, Moore KN. Post-intensive care unit syndrome in gynecologic oncology patients. Support Care Cancer. 2016;24(11):4627–32.
Silver JK, Baima J, Mayer RS. Impairment-driven cancer rehabilitation: an essential component of quality care and survivorship. CA Cancer J Clin. 2013;63(5):295–317.
Tsimopoulou I, Pasquali S, Howard R, Desai A, Gourevitch D, Tolosa I, et al. Psychological prehabilitation before cancer surgery: a systematic review. Ann Surg Oncol. 2015;22(13):4117–23.
Carli F, Brown R, Kennepohl S. Prehabilitation to enhance postoperative recovery for an octogenarian following robotic-assisted hysterectomy with endometrial cancer. Can J Anaesth. 2012;59(8):779–84.
Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
Adler J, Malone D. Early mobilization in the intensive care unit: a systematic review. Cardiopulm Phys Ther J. 2012;23(1):5–13.
Neufeld KJ, Yue J, Robinson TN, Inouye SK, Needham DM. Antipsychotic medication for prevention and treatment of delirium in hospitalized adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2016;64(4):705–14.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders : DSM-5. Arlington, VA: American Psychiatric Association; 2013.
Scholle SH, Chang JC, Harman J, Scholle SH. Trends in women’s health services by type of physician seen: data from the 1985 and 1997-98 NAMCS. Womens Health Issues. 2002;12(4):165–77.
Scholle SH, Kelleher K. Assessing primary care performance in an obstetrics/gynecology clinic. Women Health. 2003;37(1):15–30.
Coleman VH, Laube DW, Hale RW, Williams SB, Power ML, Schulkin J. Obstetrician-gynecologists and primary care: training during obstetrics-gynecology residency and current practice patterns. Acad Med. 2007;82(6):602–7.
Cerimele JM, Vanderlip ER, Croicu CA, Melville JL, Russo J, Reed SD, et al. Presenting symptoms of women with depression in an obstetrics and gynecology setting. Obstet Gynecol. 2013;122(2 Pt 1):313–8.
Bixo M, Sundstrom-Poromaa I, Bjorn I, astrom M. Patients with psychiatric disorders in gynecologic practice. Am J Obstet Gynecol. 2001;185(2):396–402.
American Congress of Obstetrician and Gynecologists. ACOG statement on depression screening. [document on the internet]. Washington, DC: American Congress of Obstetrician and Gynecologists; 2016. Available from: https://www.acog.org/About-ACOG/News-Room/Statements/2016/ACOG-Statement-on-Depression-Screening
Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.
Committee on Gynecologic Practice. Committee opinion no. 701 summary: choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2017;129(6):1149–50.
Ghant MS, Sengoba KS, Recht H, Cameron KA, Lawson AK, Marsh EE. Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women’s emotional and psychosocial health. J Psychosom Res. 2015;78(5):499–503.
Shen TC, Yang CY, Huang YJ, Lin CL, Sung FC. Risk of depression in patients with uterine leiomyoma: a nationwide population-based cohort study. J Affect Disord. 2017;213:126–30.
Haas D, Chvatal R, Reichert B, Renner S, Shebl O, Binder H, et al. Endometriosis: a premenopausal disease? Age pattern in 42, 079 patients with endometriosis. Arch Gynecol Obstet. 2012;286(3):667–70.
Lagana AS, La Rosa VL, AMC R, Valenti G, Sapia F, Chiofalo B, et al. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health. 2017;9:323–30.
Sepulcri Rde P, do Amaral VF. Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol. 2009;142(1):53–6.
Smorgick N, Marsh CA, As-Sanie S, Smith YR, Quint EH. Prevalence of pain syndromes, mood conditions, and asthma in adolescents and young women with endometriosis. J Pediatr Adolesc Gynecol. 2013;26(3):171–5.
Friedl F, Riedl D, Fessler S, Wildt L, Walter M, Richter R, et al. Impact of endometriosis on quality of life, anxiety, and depression: an Austrian perspective. Arch Gynecol Obstet. 2015;292(6):1393–9.
Lorencatto C, Petta CA, Navarro MJ, Bahamondes L, Matos A. Depression in women with endometriosis with and without chronic pelvic pain. Acta Obstet Gynecol Scand. 2006;85(1):88–92.
ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin no. 108: polycystic ovary syndrome. Obstet Gynecol. 2009;114(4):936–49.
Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab. 2015;100(3):911–9.
Cesta CE, Mansson M, Palm C, Lichtenstein P, Iliadou AN, Landen M. Polycystic ovary syndrome and psychiatric disorders: co-morbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology. 2016;73:196–203.
Hung JH, Hu LY, Tsai SJ, Yang AC, Huang MW, Chen PM, et al. Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS One. 2014;9(5):e97041.
Markland AD, Richter HE, Fwu CW, Eggers P, Kusek JW. Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008. J Urol. 2011;186(2):589–93.
Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311–6.
Waetjen LE, Liao S, Johnson WO, Sampselle CM, Sternfield B, Harlow SD, et al. Factors associated with prevalent and incident urinary incontinence in a cohort of midlife women: a longitudinal analysis of data: study of women’s health across the nation. Am J Epidemiol. 2007;165(3):309–18.
The American College of Obstetricians and Gynecologists. Committee Opinion No. 603: evaluation of uncomplicated stress urinary incontinence in women before surgical treatment. Obstet Gynecol. 2014;123(6):1403–7.
Trutnovsky G, Rojas RG, Mann KP, Dietz HP. Urinary incontinence: the role of menopause. Menopause. 2014;21(4):399–402.
Milsom I, Ekelund P, Molander U, Arvidsson L, Areskoug B. The influence of age, parity, oral contraception, hysterectomy and menopause on the prevalence of urinary incontinence in women. J Urol. 1993;149(6):1459–62.
Simeonova Z, Bengtsson C. Prevalence of urinary incontinence among women at a Swedish primary health care centre. Scand J Prim Health Care. 1990;8(4):203–6.
Wu JM, Matthews CA, Conover MM, Pate V, Jonsson Funk M. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol. 2014;123(6):1201–6.
Nygaard I, Turvey C, Burns TL, Crischilles E, Wallace R. Urinary incontinence and depression in middle-aged United States women. Obstet Gynecol. 2003;101(1):149–56.
Mishra GD, Barker MS, Herber-Gast GC, Hillard T. Depression and the incidence of urinary incontinence symptoms among young women: results from a prospective cohort study. Maturitas. 2015;81(4):456–61.
Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013;24(11):1783–90.
Ghetti C, Lowder JL, Ellison R, Krohn MA, Moalli P. Depressive symptoms in women seeking surgery for pelvic organ prolapse. Int Urogynecol J. 2010;21(7):855–60.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19–28.
Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003;54(3):269–82.
Chang HY, Keyes KM, Mok Y, Jung KJ, Shin YJ, Jee SH. Depression as a risk factor for overall and hormone-related cancer: the Korean cancer prevention study. J Affect Disord. 2015;173:1–8.
Chen CY, Yang YH, Lee CP, Wang TY, Cheng BH, Huang YC, et al. Risk of depression following uterine cancer: a nationwide population-based study. Psychooncology. 2017;26(11):1770–6.
Committee on Practice Bulletins—Gynecology. ACOG practice bulletin number 131: screening for cervical cancer. Obstet Gynecol. 2012;120(5):1222–38.
Schiffman M, Kjaer SK. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr. 2003;2003(31):14–9.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
Ferrandina G, Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, et al. Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study. Gynecol Oncol. 2012;124(3):389–94.
Yang YL, Liu L, Wang XX, Wang Y, Wang L. Prevalence and associated positive psychological variables of depression and anxiety among Chinese cervical cancer patients: a cross-sectional study. PLoS One. 2014;9(4):e94804.
American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 103: hereditary breast and ovarian cancer syndrome. Obstet Gynecol. 2009;113(4):957–66.
Watts S, Prescott P, Mason J, McLeod N, Lewith G. Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2015;5(11):e007618.
Huang T, Poole EM, Okereke OI, Kubzansky LD, Eliassen AH, Sood AK, et al. Depression and risk of epithelial ovarian cancer: results from two large prospective cohort studies. Gynecol Oncol. 2015;139(3):481–6.
Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol. 1998;179(3 Pt 1):577–82.
Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64(1):51–8.
Poromaa IS, Segebladh B. Adverse mood symptoms with oral contraceptives. Acta Obstet Gynecol Scand. 2012;91(4):420–7.
Skovlund CW, Morch LS, Kessing LV, Lidegaard O. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73(11):1154–62.
Zethraeus N, Dreber A, Ranehill E, Blomberg L, Labrie F, von Schoultz B, et al. A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial. Fertil Steril. 2017;107(5):1238–45.
Benazzi F. Gender differences in bipolar II and unipolar depressed outpatients: a 557-case study. Ann Clin Psychiatry. 1999;11(2):55–9.
Burt VK, Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disord. 2004;6(1):2–13.
Leibenluft E, Ashman SB, Feldman-Naim S, Yonkers KA. Lack of relationship between menstrual cycle phase and mood in a sample of women with rapid cycling bipolar disorder. Biol Psychiatry. 1999;46(4):577–80.
Rasgon N, Bauer M, Glenn T, Elman S, Whybrow PC. Menstrual cycle related mood changes in women with bipolar disorder. Bipolar Disord. 2003;5(1):48–52.
Shivakumar G, Bernstein IH, Suppes T, Keck PE, SL ME, Altshuler LL, et al. Are bipolar mood symptoms affected by the phase of the menstrual cycle? J Womens Health (Larchmt). 2008;17(3):473–8.
Teatero ML, Mazmanian D, Sharma V. Effects of the menstrual cycle on bipolar disorder. Bipolar Disord. 2014;16(1):22–36.
Lewis DO, Comite F, Mallouh C, Zadunaisky L, Hutchinson-Williams K, Cherksey BD, et al. Bipolar mood disorder and endometriosis: preliminary findings. Am J Psychiatry. 1987;144(12):1588–91.
Kumar V, Khan M, Vilos GA, Sharma V. Revisiting the association between endometriosis and bipolar disorder. J Obstet Gynaecol Can. 2011;33(11):1141–5.
Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med. 1993;329(19):1383–8.
Klipstein KG, Goldberg JF. Screening for bipolar disorder in women with polycystic ovary syndrome: a pilot study. J Affect Disord. 2006;91(2–3):205–9.
Rassi A, Veras AB, dos Reis M, Pastore DL, Bruno LM, Bruno RV, et al. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry. 2010;51(6):599–602.
Pope CJ, Sharma V, Sharma S, Mazmanian D. A systematic review of the association between psychiatric disturbances and endometriosis. J Obstet Gynaecol Can. 2015;37(11):1006–15.
Chen LC, Hsu JW, Huang KL, Bai YM, Su TP, Li CT, et al. Risk of developing major depression and anxiety disorders among women with endometriosis: a longitudinal follow-up study. J Affect Disord. 2016;190:282–5.
Dokras A, Clifton S, Futterweit W, Wild R. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2012;97(1):225–30.e2.
Melville JL, Walker E, Katon W, Lentz G, Miller J, Fenner D. Prevalence of comorbid psychiatric illness and its impact on symptom perception, quality of life, and functional status in women with urinary incontinence. Am J Obstet Gynecol. 2002;187(1):80–7.
Bogner HR, Gallo JJ, Swartz KL, Ford DE. Anxiety disorders and disability secondary to urinary incontinence among adults over age 50. Int J Psychiatry Med. 2002;32(2):141–54.
Ghetti C, Skoczylas LC, Oliphant SS, Nikolajski C, Lowder JL. The emotional burden of pelvic organ prolapse in women seeking treatment: a qualitative study. Female Pelvic Med Reconstr Surg. 2015;21(6):332–8.
Vrijens D, Berghmans B, Nieman F, van Os J, van Koeveringe G, Leue C. Prevalence of anxiety and depressive symptoms and their association with pelvic floor dysfunctions-A cross sectional cohort study at a Pelvic Care Centre. Neurourol Urodyn. 2017;36(7):1816–23.
Merrell J, Brethauer S, Windover A, Ashton K, Heinberg L. Psychosocial correlates of pelvic floor disorders in women seeking bariatric surgery. Surg Obes Relat Dis. 2012;8(6):792–6.
Distefano M, Riccardi S, Capelli G, Costantini B, Petrillo M, Ricci C, et al. Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy. Gynecol Oncol. 2008;111(1):144–50.
Kim SH, Kang S, Kim YM, Kim BG, Seong SJ, Cha SD, et al. Prevalence and predictors of anxiety and depression among cervical cancer survivors in Korea. Int J Gynecol Cancer. 2010;20(6):1017–24.
Lau KL, Yim PH, Cheung EY. Psychiatric morbidity in Chinese women after cervical cancer treatment in a regional gynaecology clinic. East Asian Arch Psychiatry. 2013;23(4):144–53.
Sukegawa A, Miyagi E, Asai-Sato M, Saji H, Sugiura K, Matsumura T, et al. Anxiety and prevalence of psychiatric disorders among patients awaiting surgery for suspected ovarian cancer. J Obstet Gynaecol Res. 2008;34(4):543–51.
Kessler RC, Merikangas KR. The National Comorbidity Survey Replication (NCS-R): background and aims. Int J Methods Psychiatr Res. 2004;13(2):60–8.
Tolin DF, Foa EB. Sex differences in trauma and posttraumatic stress disorder: a quantitative review of 25 years of research. Psychol Bull. 2006;132(6):959–92.
Kulka RA. Trauma and the Vietnam War generation: report of findings from the National Vietnam veterans readjustment study. New York: Routledge; 2013.
Brewin CR, Andrews B, Valentine JD. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol. 2000;68(5):748–66.
Ozer EJ, Best SR, Lipsey TL, Weiss DS. Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis. Psychol Bull. 2003;129(1):52–73.
Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048–60.
Kimerling R, Calhoun KS. Somatic symptoms, social support, and treatment seeking among sexual assault victims. J Consult Clin Psychol. 1994;62(2):333–40.
Koss MP, Woodruff WJ, Koss PG. Criminal victimization among primary care medical patients: prevalence, incidence, and physician usage. Behav Sci Law. 1991;9(1):85–96.
Swartzman S, Booth JN, Munro A, Sani F. Posttraumatic stress disorder after cancer diagnosis in adults: a meta-analysis. Depress Anxiety. 2017;34(4):327–39.
Goncalves V, Jayson G, Tarrier N. A longitudinal investigation of posttraumatic stress disorder in patients with ovarian cancer. J Psychosom Res. 2011;70(5):422–31.
Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry. 2003;60(6):565–71.
Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology. 2003;28(Suppl 2):17–54.
Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: summary of national findings, NSDUH series H-48, HHS publication no. (SMA) 14–4863. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. Available from: https://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf
Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566–76.
Randall CL, Roberts JS, Del Boca FK, Carroll KM, Connors GJ, Mattson ME. Telescoping of landmark events associated with drinking: a gender comparison. J Stud Alcohol. 1999;60(2):252–60.
Gavaler JS, Van Thiel DH. The association between moderate alcoholic beverage consumption and serum estradiol and testosterone levels in normal postmenopausal women: relationship to the literature. Alcohol Clin Exp Res. 1992;16(1):87–92.
Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995;87(17):1297–302.
Onland-Moret NC, Peeters PH, van der Schouw YT, Grobbee DE, van Gils CH. Alcohol and endogenous sex steroid levels in postmenopausal women: a cross-sectional study. J Clin Endocrinol Metab. 2005;90(3):1414–9.
Rinaldi S, Peeters PH, Bezemer ID, Dossus L, Biessy C, Sacerdote C, et al. Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control. 2006;17(8):1033–43.
Fernandez SV. Estrogen, alcohol consumption, and breast cancer. Alcohol Clin Exp Res. 2011;35(3):389–91.
Smink FR, van Hoeken D, Hoek HW. Epidemiology, course, and outcome of eating disorders. Curr Opin Psychiatry. 2013;26(6):543–8.
Kimmel MC, Ferguson EH, Zerwas S, Bulik CM, Meltzer-Brody S. Obstetric and gynecologic problems associated with eating disorders. Int J Eat Disord. 2016;49(3):260–75.
Call C, Walsh BT, Attia E. From DSM-IV to DSM-5: changes to eating disorder diagnoses. Curr Opin Psychiatry. 2013;26(6):532–6.
Hebebrand J, Muller TD, Holtkamp K, Herpertz-Dahlmann B. The role of leptin in anorexia nervosa: clinical implications. Mol Psychiatry. 2007;12(1):23–35.
Poyastro Pinheiro A, Thornton LM, Plotonicov KH, Tozzi F, Klump KL, Berrettini WH, et al. Patterns of menstrual disturbance in eating disorders. Int J Eat Disord. 2007;40(5):424–34.
Resch M, Szendei G, Haasz P. Eating disorders from a gynecologic and endocrinologic view: hormonal changes. Fertil Steril. 2004;81(4):1151–3.
Algars M, Huang L, Von Holle AF, Peat CM, Thornton LM, Lichtenstein P, et al. Binge eating and menstrual dysfunction. J Psychosom Res. 2014;76(1):19–22.
Lee I, Cooney LG, Saini S, Smith ME, Sammel MD, Allison KC, et al. Increased risk of disordered eating in polycystic ovary syndrome. Fertil Steril. 2017;107(3):796–802.
Felde G, Ebbesen MH, Hunskaar S. Anxiety and depression associated with urinary incontinence. A 10-year follow-up study from the Norwegian HUNT study (EPINCONT). Neurourol Urodyn. 2017;36(2):322–8.
Melville JL, Fan MY, Rau H, Nygaard IE, Katon WJ. Major depression and urinary incontinence in women: temporal associations in an epidemiologic sample. Am J Obstet Gynecol. 2009;201(5):490.e1–7.
Legendre G, Ringa V, Panjo H, Zins M, Fritel X. Incidence and remission of urinary incontinence at midlife: a cohort study. BJOG. 2015;122(6):816–24.
Maserejian NN, Minassian VA, Chen S, Hall SA, McKinlay JB, Tennstedt SL. Treatment status and risk factors for incidence and persistence of urinary incontinence in women. Int Urogynecol J. 2014;25(6):775–82.
Siff LN, Jelovsek JE, Barber MD. The effect of major depression on quality of life after surgery for stress urinary incontinence: a secondary analysis of the trial of midurethral slings. Am J Obstet Gynecol. 2016;215(4):455.e1–9.
Khan ZA, Whittal C, Mansol S, Osborne LA, Reed P, Emery S. Effect of depression and anxiety on the success of pelvic floor muscle training for pelvic floor dysfunction. J Obstet Gynaecol. 2013;33(7):710–4.
Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med. 2007;45(2–3):93–106.
Kaida A, Colman I, Janssen PA. Recent pap tests among Canadian women: is depression a barrier to cervical cancer screening? J Womens Health (Larchmt). 2008;17(7):1175–81.
Ludman EJ, Ichikawa LE, Simon GE, Rohde P, Arterburn D, Operskalski BH, et al. Breast and cervical cancer screening specific effects of depression and obesity. Am J Prev Med. 2010;38(3):303–10.
Pirraglia PA, Sanyal P, Singer DE, Ferris TG. Depressive symptom burden as a barrier to screening for breast and cervical cancers. J Womens Health (Larchmt). 2004;13(6):731–8.
Vigod SN, Kurdyak PA, Stewart DE, Gnam WH, Goering PN. Depressive symptoms as a determinant of breast and cervical cancer screening in women: a population-based study in Ontario, Canada. Arch Womens Ment Health. 2011;14(2):159–68.
Weitlauf JC, Jones S, Xu X, Finney JW, Moos RH, Sawaya GF, et al. Receipt of cervical cancer screening in female veterans: impact of posttraumatic stress disorder and depression. Womens Health Issues. 2013;23(3):e153–9.
Abrams MT, Myers CS, Feldman SM, Boddie-Willis C, Park J, McMahon RP, et al. Cervical cancer screening and acute care visits among Medicaid enrollees with mental and substance use disorders. Psychiatr Serv. 2012;63(8):815–22.
Osann K, Hsieh S, Nelson EL, Monk BJ, Chase D, Cella D, et al. Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials. Gynecol Oncol. 2014;135(2):266–72.
Nho JH, Kim SR, Kwon YS. Depression and appetite: predictors of malnutrition in gynecologic cancer. Support Care Cancer. 2014;22(11):3081–8.
Wilbur MB, Mannschreck DB, Angarita AM, Matsuno RK, Tanner EJ, Stone RL, et al. Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology. Gynecol Oncol. 2016;143(3):604–10.
Mahdi H, Swensen RE, Munkarah AR, Chiang S, Luhrs K, Lockhart D, et al. Suicide in women with gynecologic cancer. Gynecol Oncol. 2011;122(2):344–9.
Ward KK, Roncancio AM, Plaxe SC. Women with gynecologic malignancies have a greater incidence of suicide than women with other cancer types. Suicide Life Threat Behav. 2013;43(1):109–15.
Robson A, Scrutton F, Wilkinson L, MacLeod F. The risk of suicide in cancer patients: a review of the literature. Psychooncology. 2010;19(12):1250–8.
Noor-Mahomed SB, Schlebusch L, Bosch BA. Suicidal behavior in patients diagnosed with cancer of the cervix. Crisis. 2003;24(4):168–72.
Chochinov HM, Wilson KG, Enns M, Lander S. Depression, hopelessness, and suicidal ideation in the terminally ill. Psychosomatics. 1998;39(4):366–70.
Akechi T, Okamura H, Kugaya A, Nakano T, Nakanishi T, Akizuki N, et al. Suicidal ideation in cancer patients with major depression. Jpn J Clin Oncol. 2000;30(5):221–4.
Martinsson L, Westman J, Hallgren J, Osby U, Backlund L. Lithium treatment and cancer incidence in bipolar disorder. Bipolar Disord. 2016;18(1):33–40.
Lin GM, Chen YJ, Kuo DJ, Jaiteh LE, Wu YC, Lo TS, et al. Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009. Schizophr Bull. 2013;39(2):407–16.
BarChana M, Levav I, Lipshitz I, Pugachova I, Kohn R, Weizman A, et al. Enhanced cancer risk among patients with bipolar disorder. J Affect Disord. 2008;108(1–2):43–8.
Liang JA, Sun LM, Su KP, Chang SN, Sung FC, Muo CH, et al. A nationwide population-based cohort study: will anxiety disorders increase subsequent cancer risk? PLoS One. 2012;7(4):e36370.
Kain ZN, Sevarino F, Alexander GM, Pincus S, Mayes LC. Preoperative anxiety and postoperative pain in women undergoing hysterectomy. A repeated-measures design. J Psychosom Res. 2000;49(6):417–22.
Ciccozzi A, Marinangeli F, Colangeli A, Antonacci S, Pilerci G, Di Stefano L, et al. Anxiolysis and postoperative pain in patients undergoing spinal anesthesia for abdominal hysterectomy. Minerva Anestesiol. 2007;73(7–8):387–93.
Levandovski R, Ferreira MB, Hidalgo MP, Konrath CA, da Silva DL, Caumo W. Impact of preoperative anxiolytic on surgical site infection in patients undergoing abdominal hysterectomy. Am J Infect Control. 2008;36(10):718–26.
Seng JS, Clark MK, McCarthy AM, Ronis DL. PTSD and physical comorbidity among women receiving Medicaid: results from service-use data. J Trauma Stress. 2006;19(1):45–56.
Cohen BE, Maguen S, Bertenthal D, Shi Y, Jacoby V, Seal KH. Reproductive and other health outcomes in Iraq and Afghanistan women veterans using VA health care: association with mental health diagnoses. Womens Health Issues. 2012;22(5):e461–71.
Coker AL, Hopenhayn C, DeSimone CP, Bush HM, Crofford L. Violence against women raises risk of cervical cancer. J Womens Health (Larchmt). 2009;18(8):1179–85.
Weitlauf JC, Finney JW, Ruzek JI, Lee TT, Thrailkill A, Jones S, et al. Distress and pain during pelvic examinations: effect of sexual violence. Obstet Gynecol. 2008;112(6):1343–50.
Weitlauf JC, Frayne SM, Finney JW, Moos RH, Jones S, Hu K, et al. Sexual violence, posttraumatic stress disorder, and the pelvic examination: how do beliefs about the safety, necessity, and utility of the examination influence patient experiences? J Womens Health (Larchmt). 2010;19(7):1271–80.
Cronholm PF, Bowman MA. Women with safety concerns report fewer gender-specific preventive healthcare services. J Womens Health (Larchmt). 2009;18(7):1011–8.
Farley M, Golding JM, Minkoff JR. Is a history of trauma associated with a reduced likelihood of cervical cancer screening? J Fam Pract. 2002;51(10):827–31.
Lehavot K, Hoerster KD, Nelson KM, Jakupcak M, Simpson TL. Health indicators for military, veteran, and civilian women. Am J Prev Med. 2012;42(5):473–80.
Ryan GL, Mengeling MA, Summers KM, Booth BM, Torner JC, Syrop CH, et al. Hysterectomy risk in premenopausal-aged military veterans: associations with sexual assault and gynecologic symptoms. Am J Obstet Gynecol. 2016;214(3):352.e1–e13.
Meaney AM, O’Keane V. Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia. Life Sci. 2002;71(9):979–92.
Ebdrup NH, Assens M, Hougaard CO, Pinborg A, Hageman I, Schmidt L. Assisted reproductive technology (ART) treatment in women with schizophrenia or related psychotic disorder: a national cohort study. Eur J Obstet Gynecol Reprod Biol. 2014;177:115–20.
Ji J, Sundquist K, Ning Y, Kendler KS, Sundquist J, Chen X. Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr Bull. 2013;39(3):527–36.
Kisely S, Crowe E, Lawrence D. Cancer-related mortality in people with mental illness. JAMA Psychiatry. 2013;70(2):209–17.
Martens PJ, Chochinov HM, Prior HJ, Fransoo R, Burland E. Are cervical cancer screening rates different for women with schizophrenia? A Manitoba population-based study. Schizophr Res. 2009;113(1):101–6.
Tilbrook D, Polsky J, Lofters A. Are women with psychosis receiving adequate cervical cancer screening? Can Fam Physician. 2010;56(4):358–63.
Mo PK, Mak WW, Chong ES, Shen H, Cheung RY. The prevalence and factors for cancer screening behavior among people with severe mental illness in Hong Kong. PLoS One. 2014;9(9):e107237.
James M, Thomas M, Frolov L, Riano NS, Vittinghoff E, Schillinger D, et al. Rates of cervical cancer screening among women with severe mental illness in the public health system. Psychiatr Serv. 2017;68(8):839–42.
Woodhead C, Cunningham R, Ashworth M, Barley E, Stewart RJ, Henderson MJ. Cervical and breast cancer screening uptake among women with serious mental illness: a data linkage study. BMC Cancer. 2016;16(1):819.
Bonney WW, Gupta S, Hunter DR, Arndt S. Bladder dysfunction in schizophrenia. Schizophr Res. 1997;25(3):243–9.
Walid MS. Prevalence of urinary incontinence in female residents of American nursing homes and association with neuropsychiatric disorders. J Clin Med Res. 2009;1(1):37–9.
Hsu WY, Muo CH, Ma SP, Kao CH. Association between schizophrenia and urinary incontinence: a population-based study. Psychiatry Res. 2017;248:35–9.
Nitti VW. The prevalence of urinary incontinence. Rev Urol. 2001;3(Suppl 1):S2–6.
Maserejian NN, Kupelian V, Miyasato G, McVary KT, McKinlay JB. Are physical activity, smoking and alcohol consumption associated with lower urinary tract symptoms in men or women? Results from a population based observational study. J Urol. 2012;188(2):490–5.
Bortolotti A, Bernardini B, Colli E, Di Benedetto P, Giocoli Nacci G, Landoni M, et al. Prevalence and risk factors for urinary incontinence in Italy. Eur Urol. 2000;37(1):30–5.
Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG. 2003;110(3):247–54.
Eggert J, Theobald H, Engfeldt P. Effects of alcohol consumption on female fertility during an 18-year period. Fertil Steril. 2004;81(2):379–83.
Tolstrup JS, Kjaer SK, Holst C, Sharif H, Munk C, Osler M, et al. Alcohol use as predictor for infertility in a representative population of Danish women. Acta Obstet Gynecol Scand. 2003;82(8):744–9.
Hassan MA, Killick SR. Negative lifestyle is associated with a significant reduction in fecundity. Fertil Steril. 2004;81(2):384–92.
Klonoff-Cohen H, Lam-Kruglick P, Gonzalez C. Effects of maternal and paternal alcohol consumption on the success rates of in vitro fertilization and gamete intrafallopian transfer. Fertil Steril. 2003;79(2):330–9.
Parazzini F, Cipriani S, Bravi F, Pelucchi C, Chiaffarino F, Ricci E, et al. A metaanalysis on alcohol consumption and risk of endometriosis. Am J Obstet Gynecol. 2013;209(2):106.e1–10.
Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer. 2001;85(11):1700–5.
Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomark Prev. 2002;11(12):1531–43.
Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287(19):2559–62.
Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A, et al. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst. 2009;101(5):296–305.
Folsom AR, Demissie Z, Harnack L. Glycemic index, glycemic load, and incidence of endometrial cancer: the Iowa women’s health study. Nutr Cancer. 2003;46(2):119–24.
Friberg E, Wolk A. Long-term alcohol consumption and risk of endometrial cancer incidence: a prospective cohort study. Cancer Epidemiol Biomark Prev. 2009;18(1):355–8.
Gapstur SM, Potter JD, Sellers TA, Kushi LH, Folsom AR. Alcohol consumption and postmenopausal endometrial cancer: results from the Iowa Women’s Health Study. Cancer Causes Control. 1993;4(4):323–9.
Jain MG, Rohan TE, Howe GR, Miller AB. A cohort study of nutritional factors and endometrial cancer. Eur J Epidemiol. 2000;16(10):899–905.
Kabat GC, Miller AB, Jain M, Rohan TE. Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br J Cancer. 2008;99(5):816–21.
Loerbroks A, Schouten LJ, Goldbohm RA, van den Brandt PA. Alcohol consumption, cigarette smoking, and endometrial cancer risk: results from the Netherlands cohort study. Cancer Causes Control. 2007;18(5):551–60.
Terry P, Baron JA, Weiderpass E, Yuen J, Lichtenstein P, Nyren O. Lifestyle and endometrial cancer risk: a cohort study from the Swedish twin registry. Int J Cancer. 1999;82(1):38–42.
Fedirko V, Jenab M, Rinaldi S, Biessy C, Allen NE, Dossus L, et al. Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Ann Epidemiol. 2013;23(2):93–8.
Je Y, De Vivo I, Giovannucci E. Long-term alcohol intake and risk of endometrial cancer in the Nurses’ Health Study, 1980-2010. Br J Cancer. 2014;111(1):186–94.
Setiawan VW, Monroe KR, Goodman MT, Kolonel LN, Pike MC, Henderson BE. Alcohol consumption and endometrial cancer risk: the multiethnic cohort. Int J Cancer. 2008;122(3):634–8.
Zhou Q, Guo P, Li H, Chen XD. Does alcohol consumption modify the risk of endometrial cancer? A dose-response meta-analysis of prospective studies. Arch Gynecol Obstet. 2017;295(2):467–79.
Hennessy BT, Coleman RL, Markman M. Ovarian cancer. Lancet. 2009;374(9698):1371–82.
Chang ET, Canchola AJ, Lee VS, Clarke CA, Purdie DM, Reynolds P, et al. Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control. 2007;18(1):91–103.
Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich D, et al. Prospective study of diet and ovarian cancer. Am J Epidemiol. 1999;149(1):21–31.
Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112(3):580–93.
Rota M, Pasquali E, Scotti L, Pelucchi C, Tramacere I, Islami F, et al. Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis. Gynecol Oncol. 2012;125(3):758–63.
Felding C, Jensen LM, Tonnesen H. Influence of alcohol intake on postoperative morbidity after hysterectomy. Am J Obstet Gynecol. 1992;166(2):667–70.
Tonnesen H, Kehlet H. Preoperative alcoholism and postoperative morbidity. Br J Surg. 1999;86(7):869–74.
Karamanis G, Skalkidou A, Tsakonas G, Brandt L, Ekbom A, Ekselius L, et al. Cancer incidence and mortality patterns in women with anorexia nervosa. Int J Cancer. 2014;134(7):1751–7.
McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry. 2013;74(6):595–602.
Bhat A, Reed SD, Unutzer J. The obstetrician-gynecologist’s role in detecting, preventing, and treating depression. Obstet Gynecol. 2017;129(1):157–63.
Leddy MA, Lawrence H, Schulkin J. Obstetrician-gynecologists and women’s mental health: findings of the Collaborative Ambulatory Research Network 2005-2009. Obstet Gynecol Surv. 2011;66(5):316–23.
Katon W, Russo J, Reed SD, Croicu CA, Ludman E, LaRocco A, et al. A randomized trial of collaborative depression care in obstetrics and gynecology clinics: socioeconomic disadvantage and treatment response. Am J Psychiatry. 2015;172(1):32–40.
Melville JL, Reed SD, Russo J, Croicu CA, Ludman E, LaRocco-Cockburn A, et al. Improving care for depression in obstetrics and gynecology: a randomized controlled trial. Obstet Gynecol. 2014;123(6):1237–46.
Osborn RL, Demoncada AC, Feuerstein M. Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med. 2006;36(1):13–34.
Sternbach H. Are antidepressants carcinogenic? A review of preclinical and clinical studies. J Clin Psychiatry. 2003;64(10):1153–62.
Harlow BL, Cramer DW. Self-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer: evidence from two combined case-control studies (Massachusetts, United States). Cancer Causes Control. 1995;6(2):130–4.
Coogan PF, Rosenberg L, Palmer JR, Strom BL, Stolley PD, Zauber AG, et al. Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States). Cancer Causes Control. 2000;11(9):839–45.
Wu CS, Lu ML, Liao YT, Lee CT, Chen VC. Ovarian cancer and antidepressants. Psychooncology. 2015;24(5):579–84.
Lin CF, Chan HL, Hsieh YH, Liang HY, Chiu WC, Huang KY, et al. Endometrial cancer and antidepressants: a nationwide population-based study. Medicine (Baltimore). 2016;95(29):e 4178.
Chan HL, Hsieh YH, Lin CF, Liang HY, Huang KY, Chiu WC, et al. Invasive cervical cancer and antidepressants: a nationwide population-based study. Medicine (Baltimore). 2015;94(42):e1866.
Christensen DK, Armaiz-Pena GN, Ramirez E, Matsuo K, Zimmerman B, Zand B, et al. SSRI use and clinical outcomes in epithelial ovarian cancer. Oncotarget. 2016;7(22):33179–91.
Pillarella J, Higashi A, Alexander GC, Conti R. Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009. Psychiatr Serv. 2012;63(1):83–6.
Anderson EL, Reti IM. ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med. 2009;71(2):235–42.
Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry. 1994;45(5):444–50.
Saatcioglu O, Tomruk NB. The use of electroconvulsive therapy in pregnancy: a review. Isr J Psychiatry Relat Sci. 2011;48(1):6–11.
Patsalos PN, Froscher W, Pisani F, van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia. 2002;43(4):365–85.
Sabers A, Buchholt JM, Uldall P, Hansen EL. Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res. 2001;47(1–2):151–4.
Galimberti CA, Mazzucchelli I, Arbasino C, Canevini MP, Fattore C, Perucca E. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy. Epilepsia. 2006;47(9):1569–72.
Ismaili E, Walsh S, O’Brien PMS, Backstrom T, Brown C, Dennerstein L, et al. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016;19(6):953–8.
Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, et al. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med. 1995;332(23):1529–34.
Marjoribanks J, Brown J, O’Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013;(6):Cd001396. Available from: https://doi.org/10.1002/14651858.CD001396.pub3.
National Institute for Health and Care Excellence. General anxiety disorder and panic disorder in adults: management. [Document on the Internet]. London: National Institute for Health and Care Excellence; 2011. Available from: https://www.nice.org.uk/guidance/cg113/chapter/1-Guidance
Fitelson E, McGibbon C. Evaluation and management of behavioral health disorders in women: an overview of major depression, bipolar disorder, anxiety disorders, and sleep in the primary care setting. Obstet Gynecol Clin N Am. 2016;43(2):231–46.
Davidson JR, Zhang W, Connor KM, Ji J, Jobson K, Lecrubier Y, et al. A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). J Psychopharmacol. 2010;24(1):3–26.
Kain ZN, Mayes LC, Bell C, Weisman S, Hofstadter MB, Rimar S. Premedication in the United States: a status report. Anesth Analg. 1997;84(2):427–32.
Caumo W, Levandovski R, Hidalgo MP. Preoperative anxiolytic effect of melatonin and clonidine on postoperative pain and morphine consumption in patients undergoing abdominal hysterectomy: a double-blind, randomized, placebo-controlled study. J Pain. 2009;10(1):100–8.
Caumo W, Torres F, Moreira NL Jr, Auzani JA, Monteiro CA, Londero G, et al. The clinical impact of preoperative melatonin on postoperative outcomes in patients undergoing abdominal hysterectomy. Anesth Analg. 2007;105(5):1263–71, table of contents.
Hidalgo MP, Auzani JA, Rumpel LC, Moreira NL Jr, Cursino AW, Caumo W. The clinical effect of small oral clonidine doses on perioperative outcomes in patients undergoing abdominal hysterectomy. Anesth Analg. 2005;100(3):795–802, table of contents.
Joseph TT, Krishna HM, Kamath S. Premedication with gabapentin, alprazolam or a placebo for abdominal hysterectomy: effect on pre-operative anxiety, post-operative pain and morphine consumption. Indian J Anaesth. 2014;58(6):693–9.
Vitale AT, O’Connor PC. The effect of Reiki on pain and anxiety in women with abdominal hysterectomies: a quasi-experimental pilot study. Holist Nurs Pract. 2006;20(6):263–72. quiz 73–4.
Watts BV, Schnurr PP, Mayo L, Young-Xu Y, Weeks WB, Friedman MJ. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry. 2013;74(6):e541–50.
Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW. Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: systemic review and meta-analyses to determine first-line treatments. Depress Anxiety. 2016;33(9):792–806.
Department of Veterans Affairs/Department of Defense. The Management of Posttraumatic Stress Disorder Work Group. VA/DOD Clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder [Document on the Internet]. Washington, DC: Department of Veterans Affairs/Department of Defense; 2017. Available from: https://www.healthquality.va.gov/guidelines/MH/ptsd/VADoDPTSDCPGFinal.pdf
Lindamer LA, Buse DC, Lohr JB, Jeste DV. Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biol Psychiatry. 2001;49(1):47–51.
Kulkarni J, de Castella A, Fitzgerald PB, Gurvich CT, Bailey M, Bartholomeusz C, et al. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry. 2008;65(8):955–60.
Akhondzadeh S, Nejatisafa AA, Amini H, Mohammadi MR, Larijani B, Kashani L, et al. Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial. Prog Neuro-Psychopharmacol Biol Psychiatry. 2003;27(6):1007–12.
Usall J, Huerta-Ramos E, Labad J, Cobo J, Nunez C, Creus M, et al. Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial. Schizophr Bull. 2016;42(2):309–17.
Kulkarni J, Gavrilidis E, Gwini SM, Worsley R, Grigg J, Warren A, et al. Effect of adjunctive raloxifene therapy on severity of refractory schizophrenia in women: a randomized clinical trial. JAMA Psychiatry. 2016;73(9):947–54.
Thompson KN, Kulkarni J, Sergejew AA. Extrapyramidal symptoms and oestrogen. Acta Psychiatr Scand. 2000;101(2):130–4.
Hand DJ, Short VL, Abatemarco DJ. Treatments for opioid use disorder among pregnant and reproductive-aged women. Fertil Steril. 2017;108(2):222–7.
Baser O, Chalk M, Rawson R, Gastfriend DR. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence. Am J Manag Care. 2011;17(Suppl 8):S222–34.
Zindel LR, Kranzler HR. Pharmacotherapy of alcohol use disorders: seventy-five years of progress. J Stud Alcohol Drugs Suppl. 2014;75(Suppl 17):79–88.
DeVido J, Bogunovic O, Weiss RD. Alcohol use disorders in pregnancy. Harv Rev Psychiatry. 2015;23(2):112–21.
Gianoulakis C. Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J Psychiatry Neurosci. 2001;26(4):304–18.
Canidate SS, Carnaby GD, Cook CL, Cook RL. A systematic review of naltrexone for attenuating alcohol consumption in women with alcohol use disorders. Alcohol Clin Exp Res. 2017;41(3):466–72.
Littleton JM. Acamprosate in alcohol dependence: implications of a unique mechanism of action. J Addict Med. 2007;1(3):115–25.
Mason BJ, Lehert P. Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data. Alcohol Clin Exp Res. 2012;36(3):497–508.
Oppedal K, Moller AM, Pedersen B, Tonnesen H. Preoperative alcohol cessation prior to elective surgery. Cochrane Database Syst Rev. 2012;7:Cd008343.
Tonnesen H, Nielsen PR, Lauritzen JB, Moller AM. Smoking and alcohol intervention before surgery: evidence for best practice. Br J Anaesth. 2009;102(3):297–306.
Horne RL, Ferguson JM, Pope HG Jr, Hudson JI, Lineberry CG, Ascher J, et al. Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry. 1988;49(7):262–6.
Mondraty N, Birmingham CL, Touyz S, Sundakov V, Chapman L, Beumont P. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australas Psychiatry. 2005;13(1):72–5.
Brambilla F, Garcia CS, Fassino S, Daga GA, Favaro A, Santonastaso P, et al. Olanzapine therapy in anorexia nervosa: psychobiological effects. Int Clin Psychopharmacol. 2007;22(4):197–204.
Bissada H, Tasca GA, Barber AM, Bradwejn J. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 2008;165(10):1281–8.
Bosanac P, Kurlender S, Norman T, Hallam K, Wesnes K, Manktelow T, et al. An open-label study of quetiapine in anorexia nervosa. Hum Psychopharmacol. 2007;22(4):223–30.
Zerbe KJ. Eating disorders in the 21st century: identification, management, and prevention in obstetrics and gynecology. Best Pract Res Clin Obstet Gynaecol. 2007;21(2):331–43.
Eisler I, Dare C, Russell GF, Szmukler G, le Grange D, Dodge E. Family and individual therapy in anorexia nervosa. A 5-year follow-up. Arch gen. Psychiatry. 1997;54(11):1025–30.
Dare C, Eisler I, Russell G, Treasure J, Dodge L. Psychological therapies for adults with anorexia nervosa: randomised controlled trial of out-patient treatments. Br J Psychiatry. 2001;178:216–21.
Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry. 1992;49(2):139–47.
Hoopes SP, Reimherr FW, Hedges DW, Rosenthal NR, Kamin M, Karim R, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry. 2003;64(11):1335–41.
Nickel C, Tritt K, Muehlbacher M, Pedrosa Gil F, Mitterlehner FO, Kaplan P, et al. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. Int J Eat Disord. 2005;38(4):295–300.
Brownley KA, Berkman ND, Peat CM, Lohr KN, Cullen KE, Bann CM, et al. Binge-eating disorder in adults: a systematic review and meta-analysis. Ann Intern Med. 2016;165(6):409–20.
Hudson JI, McElroy SL, Ferreira-Cornwell MC, Radewonuk J, Gasior M. Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder: a randomized clinical trial. JAMA Psychiatry. 2017;74(9):903–10.
McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry. 2007;61(9):1039–48.
Claudino AM, de Oliveira IR, Appolinario JC, Cordas TA, Duchesne M, Sichieri R, et al. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. J Clin Psychiatry. 2007;68(9):1324–32.
Carpenter J, Gass MLS, Maki PM, Newton KM, Pinkerton JV. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of the North American Menopause Society. Menopause. 2015;22(11):1155–72. quiz 73–4.
Brown JN, Wright BR. Use of gabapentin in patients experiencing hot flashes. Pharmacotherapy. 2009;29(1):74–81.
Hayes LP, Carroll DG, Kelley KW. Use of gabapentin for the management of natural or surgical menopausal hot flashes. Ann Pharmacother. 2011;45(3):388–94.
Loprinzi CL, Qin R, Balcueva EP, Flynn KA, Rowland KM Jr, Graham DL, et al. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol. 2010;28(4):641–7.
Carey ET, Till SR, As-Sanie S. Pharmacological management of chronic pelvic pain in women. Drugs. 2017;77(3):285–301.
Lewis SC, Bhattacharya S, Wu O, Vincent K, Jack SA, Critchley HO, et al. Gabapentin for the management of chronic pelvic pain in women (GaPP1): a pilot randomised controlled trial. PLoS One. 2016;11(4):e0153037.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ho, P. (2019). Psychiatric Aspects of Obstetrics and Gynecology Patients. In: Zimbrean, P., Oldham, M., Lee, H. (eds) Perioperative Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-99774-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-99774-2_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99773-5
Online ISBN: 978-3-319-99774-2
eBook Packages: MedicineMedicine (R0)